SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001019056-22-000192
Filing Date
2022-02-14
Accepted
2022-02-14 15:15:30
Documents
2
Group Members
ROSALIND ADVISORS, INC.ROSALIND MASTER FUND L.P.STEVEN SALAMON

Document Format Files

Seq Description Document Type Size
1 SC 13G/A plxpharma_13ga2.htm SC 13G/A 107192
2 EXHIBIT A ex_a.htm EX-99.A 7217
  Complete submission text file 0001019056-22-000192.txt   116230
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Subject) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88072 | Film No.: 22630315
SIC: 2834 Pharmaceutical Preparations

Mailing Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8
Business Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1130
Type: SC 13G/A